Do anti-carbamylated protein antibodies in rheumatoid arthritis reflect local and systemic osteoporosis? A study of osteoprotegrin and receptor activator for nuclear factor kappa B ligand and radiological assessment
Open Access
- 23 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1), 1-6
- https://doi.org/10.1186/s43166-021-00067-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisAutoimmunity Reviews, 2012
- Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damageProceedings of the National Academy of Sciences of the United States of America, 2011
- Factors Influencing Fracture Risk, T Score, and Management of Osteoporosis in Patients With Rheumatoid Arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) RegistryJCR: Journal of Clinical Rheumatology, 2009
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and DiseaseEndocrine Reviews, 2007
- RANK and RANKL expression as markers of dendritic cell–t cell interactions in paired samples of rheumatoid synovium and lymph nodesArthritis & Rheumatism, 2005
- C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and FunctionCirculation, 2004
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Routine quantification of rheumatoid factor by rate nephelometry.Annals Of The Rheumatic Diseases, 1985
- Hemoglobin Carbamylation in UremiaThe New England Journal of Medicine, 1981
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980